Skip to main content

Strengthening Preparedness Against Novel Biological Threat Agents Enabled Through Artificial Intelligence and Other Emerging Technologies

In formation

Artificial intelligence (AI)-enabled tools are accelerating advances in biotechnology, offering powerful new capabilities for medical countermeasure (MCM) development. These technologies can expand the bioeconomy, strengthen global leadership in standards and innovation, and dramatically improve the speed, accuracy, and scalability of systems that detect, predict, and respond to biological threats, while also introducing new risks for misuse. The National Academies and National Academy of Medicine will conduct an international workshop and consensus study to examine the challenge of responding to unique biological threats designed using AI-enabled tools, opportunities to accelerate MCM against AI-enabled threats, and strategies for reducing associated risks.

Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.